BlueDot Information

Toronto-based infectious disease intelligence company, BlueDot, has developed a first-of-its-kind, global early warning technology for infectious diseases. Using artificial and human intelligence, BlueDot’s outbreak risk platform tracks over 120 infectious diseases globally in 65 languages, around the clock and anticipates their spread and impact. They empower national and international health agencies, pharma and life sciences companies, and businesses to better anticipate, and respond to, emerging threats. BlueDot was among the first in the world to identify the emerging risk from, and publish a scientific paper on, COVID-19, and delivers regular critical Insights to its partners and customers worldwide to mobilize timely, effective, efficient, coordinated, and measured responses. BlueDot was founded in 2013 by Dr. Kamran Khan, a practicing infectious disease physician, and Professor of Medicine with the Division of Infectious Diseases at the University of Toronto. Motivated by his experiences as a frontline healthcare worker during the 2003 Toronto SARS outbreak, Dr. Khan has been studying the outbreak of infectious diseases over the past 15 years to lay the scientific foundation for BlueDot’s early warning system.